Finance

Lists
CLOV:NASDAQ
Clover Health Investments Corp
3,73 $
-1,06%
(-0,040) 1D
3,75 $
+0,57% (+0,021)
After hours
Closed: 20 նոյ, 16:00:02 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CLOV...
Open
3,75 $
High
3,96 $
Low
3,68 $
Mkt. cap
2,00 մլրդ
Avg. vol.
4,86 մլն
Volume
7,25 մլն
P/E ratio
197,67
52-wk high
5,59 $
52-wk low
1,58 $
EPS
0,02 $
Beta
2,52
Shares outstanding
435,44 մլն
No. of employees
724
Open
3,75 $
High
3,96 $
Low
3,68 $
Mkt. cap
2,00 մլրդ
Avg. vol.
4,86 մլն
Volume
7,25 մլն
P/E ratio
197,67
52-wk high
5,59 $
52-wk low
1,58 $
EPS
0,02 $
Beta
2,52
Shares outstanding
435,44 մլն
No. of employees
724
News stories
From web sources and news partners
Profile
Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021. Wikipedia
About Clover Health Investments Corp
CEOAndrew Toy
Employees724
Founded2014 թ. հլս 17
HeadquartersՋերսի Սիթի, Նյու Ջերսի, Միացյալ Նահանգներ
SectorHealth Care
IndustryHealth care provider
Analyst ratings
Based on 4 analysts giving stock ratings to CLOV in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for CLOV in the last 3 months.
Highest
Current 3,73 $
6,00 $ (+60,86%)
Average
5,75 $ (+54,16%)
Lowest
5,50 $ (+47,45%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jonathan Yong
UBS
Hold
Reiterated
5,50 $
+47,5%
11/05/2026
Richard Close
Canaccord Genuity
Buy
Reiterated
5,50 $
+47,5%
11/05/2026
Matthew Shea
Needham
Buy
Initiated
6,00 $
+60,9%
10/28/2026
George Hill
Deutsche Bank
Buy
Initiated
6,00 $
+60,9%
09/11/2026
Whit Mayo
Leerink Partners
Hold
Maintained
3,00 $
-19,6%
10/22/2025
Last report
2026 թ. նոյ 5
Fiscal period
Q3 2026
0,03 $ / 0,01 $
+177,00%beat
Revenue / Est. (USD)
759,30 մլն / 747,65 մլն
+1,56%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
2026 թ. սեպ
Revenue
487,71 մլն
749,19 մլն
743,17 մլն
759,30 մլն
Cost of goods sold
413,50 մլն
589,65 մլն
590,16 մլն
629,46 մլն
Cost of revenue
413,50 մլն
589,65 մլն
590,16 մլն
629,46 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
123,11 մլն
131,69 մլն
124,44 մլն
122,80 մլն
Operating expense
123,53 մլն
132,21 մլն
125,00 մլն
123,41 մլն
Total operating expenses
537,03 մլն
721,86 մլն
715,17 մլն
752,87 մլն
Operating income
-49,32 մլն
27,33 մլն
28,00 մլն
6,44 մլն
Other non operating income
-1,00 հզր
-
-
-
EBT including unusual items
-49,32 մլն
27,33 մլն
28,00 մլն
6,44 մլն
EBT excluding unusual items
-49,32 մլն
27,33 մլն
28,00 մլն
6,44 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-49,32 մլն
27,33 մլն
28,00 մլն
6,44 մլն
Net profit margin
-10,11%
3,65%
3,77%
0,85%
Earnings per share
-0,05
0,07
0,07
0,03
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
420,00 հզր
515,00 հզր
564,00 հզր
610,00 հզր
EBITDA
-48,90 մլն
27,85 մլն
28,56 մլն
7,04 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google Apps